Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Biotech leader Kiniksa stock is poised to hit a fresh buy point after shares soared 25% in response to better-than-expected sales numbers.
The post Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat appeared first on Investor’s Business Daily.
